- Infinity Pharmaceuticals (NASDAQ:INFI) announces the appointment of Robert Ilaria as the company's chief medical officer.
- Ilaria joins Infinity from Bristol Myers Squibb where he was most recently the CTLA-4 Development Program Leader.
- Infinity also announces that Brian Schwartz will be transitioning from his role as Consulting Chief Physician to the the company's board of directors.
- Schwartz has over 25 years of experience as a drug development expert in pharmaceutical and biotechnology industries and has served as Infinity’s consulting Chief Physician since early 2020.
Infinity Pharmaceuticals names Robert Ilaria as chief medical officer
Recommended For You
More Trending News
About INFIQ Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
INFIQ | - | - |
Infinity Pharmaceuticals, Inc. |